Impax Laboratories, Inc.

    Impax Laboratories, Inc.

    NNASDAQ:IPXL
    - -
    USD
    - -
    - -
    Impax Laboratories, Inc.
    NASDAQ:IPXL
    (Nasdaq Stock Market)

    Recent

    price

    - -

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    1999
    2000
    2001
    2002
    2003
    2007
    2008
    2009
    2010
    2011
    2012
    2013
    2014
    2015
    2016
    2017
    TTM
    USD
    0.16
    0.37
    0.16
    0.52
    1.15
    4.65
    3.56
    5.95
    14.18
    8
    8.86
    7.64
    8.74
    12.36
    11.59
    - -
    10.8
    Revenue per Share
    -1.12
    -0.91
    -0.6
    -0.42
    -0.28
    2.14
    0.32
    0.83
    4.04
    1.02
    0.85
    1.51
    0.84
    0.56
    -6.63
    - -
    -6.53
    Basic EPS, GAAP
    -0.9
    -0.71
    -0.83
    -0.64
    -0.46
    1.7
    0.66
    -0.37
    3.76
    -0.38
    -1
    1.57
    -0.15
    0.59
    0.3
    - -
    0.8
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    -2.5
    -1.63
    -1.68
    -1.89
    -2.03
    -1.02
    -0.69
    0.02
    4.06
    4.95
    5.69
    7.09
    7.8
    8.2
    1.39
    - -
    -5.17
    Book Value per Share
    -1.12
    -0.07
    0.57
    0.27
    0.74
    1.81
    2.23
    3.23
    7.75
    8.97
    9.38
    11.25
    12.23
    3.59
    -2.86
    - -
    -3.93
    Tangible Book Value per Share
    8
    28
    42
    47
    51
    59
    59
    60
    62
    64
    66
    67
    68
    70
    71
    - -
    72
    Basic Weighted Avg Shares
    1
    10
    7
    25
    59
    274
    210
    358
    880
    513
    582
    512
    596
    860
    824
    - -
    776
    Sales/Revenue/Turnover
    -752.66
    -246.73
    -384.31
    -84.82
    -23.01
    31.61
    4.95
    19.65
    45.45
    20.88
    14.27
    -1.25
    15.8
    8.62
    -58.99
    - -
    -44.62
    Operating Margin (%)
    1
    6
    6
    3
    4
    9
    10
    11
    13
    16
    78
    36
    34
    69
    88
    - -
    109
    Depreciation Expense
    -9
    -25
    -25
    -20
    -14
    126
    19
    50
    250
    65
    56
    101
    57
    39
    -472
    - -
    -469
    Net Income, GAAP
    - -
    - -
    - -
    - -
    - -
    - -
    36.98
    29.6
    36.44
    33.28
    32.93
    31.09
    36.67
    34.31
    - -
    - -
    - -
    Effective Tax Rate (%)
    -721.69
    -245.44
    -380.99
    -81.75
    -24.15
    46
    8.9
    13.97
    28.47
    12.77
    9.61
    19.8
    9.62
    4.53
    -57.26
    - -
    -60.49
    Profit Margin (%)
    6
    18
    36
    5
    13
    110
    127
    170
    394
    443
    400
    506
    572
    495
    310
    341
    341
    Working Capital
    1
    1
    7
    9
    9
    21
    6
    - -
    - -
    - -
    - -
    - -
    - -
    425
    814
    770
    770
    LT Debt
    30
    31
    52
    41
    66
    134
    159
    222
    508
    603
    691
    810
    888
    1,062
    624
    187
    187
    Total Equity
    - -
    - -
    - -
    - -
    - -
    - -
    3.24
    24.65
    69.34
    12.82
    8.58
    -0.64
    8.37
    5.35
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    419.17
    -539.03
    197.52
    23.07
    16.3
    23.95
    11.4
    7.45
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    197.69
    23.01
    16.18
    23.89
    11.4
    7.07
    -140.93
    - -
    - -
    Return on Common Equity (%)

    Capital Structure

    USD

    •

    in mil. unless spec.
    Jun'17
    Sep'17
    Dec'17
    ST Debt
    18
    18
    18
    LT Borrowings
    766
    768
    770
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    74
    74
    74
    Market Capitalization
    1,152
    1,456
    1,196

    Working Capital

    USD

    •

    in mil. unless spec.
    Jun'17
    Sep'17
    Dec'17
    Total Current Assets
    628
    633
    696
    Cash, Cash Equivalents & STI
    171
    158
    182
    Accounts Receivable, Net
    220
    242
    241
    Inventories
    200
    173
    158
    Total Current Liabilities
    359
    349
    354
    Payables & Accruals
    286
    270
    329
    ST Debt
    18
    18
    18
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    15.54%
    -12.96%
    -70%
    Free Cash Flow
    - -
    - -
    - -
    Net Income, GAAP
    - -
    - -
    - -
    Sales/Revenue/Turnover
    - -
    - -
    - -
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2015
    143
    214
    221
    282
    860
    2016
    226
    173
    228
    198
    824
    2017
    184
    202
    206
    183
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2015
    -0.09
    -0.03
    0.51
    0.16
    0.56
    2016
    -0.15
    -0.04
    -2.51
    -3.91
    -6.63
    2017
    -1.37
    -0.28
    -0.69
    -4.18
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2015
    - -
    - -
    - -
    - -
    - -
    2016
    - -
    - -
    - -
    - -
    - -
    2017
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business